Diligence memo · auto-generated · as of July 2, 2026
Ablative Solutions, Inc.
Ablative Solutions, Inc. looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Ablative Solutions, Inc. operates in Other Health Care, based in WAKEFIELD.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Ablative Solutions, Inc. has raised $180M in disclosed capital across 11 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $54M on 2018-12-28.
Most recent recorded round closed around 2025-11-14.
Valuation (modeled)modeled
Provath models Ablative Solutions, Inc. at approximately $60M (range $38M–$75M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.26× the median modeled value of Series C Other Health Care companies in 2025–2027 (20 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 8 months.
Last raise 8 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 3.6× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 98% of Other Health Care peers (5376 compared).
Modeled value ranks above 69% of those peers.
Closest niche peers: RESTOR3D, Inc., ByHeart, Inc., SpyGlassPharma, Inc., VantAI Holdings, Inc., BioIntelliSense, Inc..
Peoplefiled
24 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.